SGTL2 Inhibitors and Amputations in the US FDA Adverse Event Reporting System
Fadini GP, Avogaro A
Lancet Diabetes Endocrinol 2017;5(9):680-1
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Fadini GP, Avogaro A
Lancet Diabetes Endocrinol 2017;5(9):680-1
Leggi
D’Errico MM, Mangiacotti A, Graziano D, Massa V, Piscitelli P, Vendemiale G, Viazzi F, Pontremoli R, Russo E, Marchese N, Vigna C, De Cosmo S
Acta Diabetologica. Pub. online July 21, 2017
Leggi
Byrne JL, Davies MJ, Willaing I, et al.
Diabetic Medicine 2017;34(8):1074-83
Leggi
Odgers Jewell K, Ball L, Kelly JT, et al.
Diabetic Medicine 2017;34(8):1027.39
Leggi
Kouidrat Y, Pizzol D, Cosco T, et al.
Diabetic Medicine. Pub. online 18 July 2017
Leggi
Chang CH, Yeh YC, Shih SR, et al.
Diabetic Medicine. Pub. online 14 July 2017
Leggi
Ioannidis JPA
JAMA. Pub. online July 24, 2017
Leggi
Krumholz HM
JAMA. Pub. online July 24, 2017
Leggi
Varban OA, Cassidy RB, Bonham A, et al.
JAMA Surg. Pub. online July 26, 2017
Leggi
Jones CE, Graham LA, Morris MS, et al.
JAMA Surg. Pub.online July 26, 2017
Leggi